{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:15:29Z","timestamp":1744431329582,"version":"3.40.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Prisoners are at a higher risk of communicable diseases (such as HIV and hepatitis) than the general population. Therefore, medical screening is crucial for early diagnosis, treatment, identifying those at higher risk of infection, and prevention of infection spread.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>The main objective of this study was to analyze the factors associated with hepatitis B and C seropositivity in the prison population in Montenegro in two consecutive study years.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>Prisoners of Prison for Short and Long prison terms in Spu\u017e, Montenegro, were included in two cross-sectional studies during 2012 and 2021. Data on socio-demographic factors, risky behavior, and preventive measures related to blood-borne viruses were collected. The data were statistically processed by statistical testing of differences and applying regression models in SPSS Windows, version 19.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 506 prisoners (2012\u2013298; 2021\u2013208) were included in this study. One fifth of prisoners were seropositive for viral hepatitis B (2012\u20130.7%; 2021\u20133.4%) or C (2012\u201321.8%; 2021-20.7%) or both (2012\u20130.33%; 2021\u20130.0%). Factors associated with viral hepatitis B and C seropositivity in both years were shorter prison terms served and injection drug use. Additionally, factors associated with prisoners seropositivity in 2012 were ever drug use and lack of free hygiene kits in prison, and in 2021 were condom use with a permanent partner, non-condom use with non-permanent partner, and availability of free syringes and needles distribution.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion and recommendation<\/jats:title>\n<jats:p>Prevalent risky behaviors and the lack of harm reduction interventions are more common among seropositive prisoners. Establishing a prison hospital, improving the surveillance system, introducing new or improving old harm reduction interventions is imperative.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0321464","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:24:11Z","timestamp":1744392251000},"page":"e0321464","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with the prevalence of viral hepatitis B and C among prisoners: Results of two consecutive national surveys in Montenegro"],"prefix":"10.1371","volume":"20","author":[{"given":"Marijan","family":"Baki\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Stevanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5575-0587","authenticated-orcid":true,"given":"Marija","family":"Mili\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Gali\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Baki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adis","family":"Martinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Baki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"\u0160trbac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u0161ko","family":"Baki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radmila","family":"Balaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milorad","family":"Vujni\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-2539","authenticated-orcid":true,"given":"Bojan","family":"Joksimovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"pone.0321464.ref001","article-title":"Prison and drugs in Europe: current and future challenges, Publications Office of the European Union, Luxembourg","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2022"},{"key":"pone.0321464.ref002","author":"World Health Organisation","year":"2023"},{"key":"pone.0321464.ref003","article-title":"People in prisons and other closed settings.","author":"World Health Organisation"},{"issue":"7","key":"pone.0321464.ref004","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1473-3099(18)30756-4","article-title":"Challenges and opportunities for the management of infectious diseases in Europes\u2019 prisons: evidence-based guidance","volume":"19","author":"L Tavoschi","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pone.0321464.ref005","unstructured":"European Centre for Disease Prevention and Control and the European Monitoring Centre for Drugs and Drug Addiction. Systematic review on active case finding of communicable diseases in prison settings. Stockholm: ECDC; 2017."},{"issue":"10049","key":"pone.0321464.ref006","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"K Dolan","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"pone.0321464.ref007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/epirev\/mxy003","article-title":"HIV and Viral Hepatitis Among Imprisoned Key Populations","volume":"40","author":"AL Wirtz","year":"2018","journal-title":"Epidemiol Rev"},{"issue":"1","key":"pone.0321464.ref008","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12879-018-2988-x","article-title":"Hepatitis B\/C in the countries of the EU\/EEA: a systematic review of the prevalence among at-risk groups","volume":"18","author":"AM Falla","year":"2018","journal-title":"BMC Infect Dis"},{"key":"pone.0321464.ref009","volume-title":"Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations","year":"2022"},{"key":"pone.0321464.ref010","author":"Global AIDS Strategy 2021\u20132026","year":"2021","journal-title":"End Inequalities. End AIDS. Geneva: Joint United Nations Programme on HIV\/AIDS"},{"issue":"1","key":"pone.0321464.ref011","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12954-021-00506-3","article-title":"The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases","volume":"18","author":"H St\u00f6ver","year":"2021","journal-title":"Harm Reduct J"},{"key":"pone.0321464.ref012","author":"Institute of public health of Montenegro"},{"key":"pone.0321464.ref013","author":"CPT"},{"key":"pone.0321464.ref014","author":"UNAIDS","year":"2022"},{"key":"pone.0321464.ref015","volume-title":"Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. World Health Organization","author":"WHO Library Cataloguing-in-Publication Data","year":"2016"},{"key":"pone.0321464.ref016","author":"World Health Organization","year":"2017"},{"issue":"1","key":"pone.0321464.ref017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12954-023-00774-1","article-title":"HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice","volume":"20","author":"H St\u00f6ver","year":"2023","journal-title":"Harm Reduct J"},{"issue":"11","key":"pone.0321464.ref018","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1017\/S0950268810000476","article-title":"Viral hepatitis B, C and HIV infection in Croatian prisons","volume":"138","author":"V Burek","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"2","key":"pone.0321464.ref019","doi-asserted-by":"crossref","first-page":"e31598","DOI":"10.5812\/jjm.31598","article-title":"The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey","volume":"9","author":"D Keten","year":"2016","journal-title":"Jundishapur J Microbiol"},{"issue":"1","key":"pone.0321464.ref020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40249-021-00876-7","article-title":"The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis","volume":"10","author":"H Ahmadi Gharaei","year":"2021","journal-title":"Infect Dis Poverty"},{"issue":"1\u20132","key":"pone.0321464.ref021","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2012.05.008","article-title":"High-risk drug-use practices among a large sample of Australian prisoners","volume":"126","author":"SA Kinner","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"pone.0321464.ref022","article-title":"World Drug Report 2011","author":"UNODC","year":"2011","journal-title":"New York: United Nations Office on Drugs and Crime"},{"issue":"17","key":"pone.0321464.ref023","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200411190-00010","article-title":"Global overview of injecting drug use and HIV infection among injecting drug users","volume":"18","author":"United Nations Reference Group on HIV\/AIDS Prevention and Care among IDU in Developing and Transitional Countries","year":"2004","journal-title":"AIDS"},{"issue":"1\u20132","key":"pone.0321464.ref024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2009.03.005","article-title":"The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico","volume":"103","author":"RA Pollini","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"pone.0321464.ref025","doi-asserted-by":"crossref","first-page":"A287.1-A287","DOI":"10.1136\/sextrans-2013-051184.0893","article-title":"P3.443\u2005Risk Behaviour and Risk Factors For HIV and Other STI Among Prisoners in Serbia","volume":"89","author":"M Krstic","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"7","key":"pone.0321464.ref026","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/add.12938","article-title":"Incarceration and injection drug use in Baltimore, Maryland","volume":"110","author":"BL Genberg","year":"2015","journal-title":"Addiction"},{"issue":"9791","key":"pone.0321464.ref027","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"PK Nelson","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"pone.0321464.ref028","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/cid\/ciz669","article-title":"Prevalence of Hepatitis B Virus Infection Among US Adults Aged 20-59 Years With a History of Injection Drug Use: National Health and Nutrition Examination Survey, 2001-2016","volume":"70","author":"JZ Shing","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0321464.ref029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1108\/IJPH-02-2021-0018","article-title":"HIV\/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review","volume":"18","author":"RJ Bosworth","year":"2022","journal-title":"Int J Prison Health"},{"issue":"7","key":"pone.0321464.ref030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/cid\/cir491","article-title":"Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy","volume":"53","author":"RP Westergaard","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0321464.ref031","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/epirev\/mxy002","article-title":"Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates","volume":"40","author":"B Moazen","year":"2018","journal-title":"Epidemiol Rev"},{"issue":"2","key":"pone.0321464.ref032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1071\/SH11038","article-title":"Sexual behaviour of inmates with Chlamydia trachomatis infection in the prisons of Catalonia, Spain","volume":"9","author":"EL Corbeto","year":"2012","journal-title":"Sex Health"},{"issue":"10195","key":"pone.0321464.ref033","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(19)30279-X","article-title":"The guidelines on infection control in prisons need revising","volume":"394","author":"B Moazen","year":"2019","journal-title":"Lancet"},{"key":"pone.0321464.ref034","volume-title":"Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations","year":"2022"},{"key":"pone.0321464.ref035","article-title":"Availability, coverage and barriers towards condom provision in prisons: a review of the evidence","author":"B Moazen","year":"2019","journal-title":"Frankfurt am Main: Institut f\u00fcr Suchtforschung (ISFF), Frankfurt University of Applied Sciences"},{"issue":"5","key":"pone.0321464.ref036","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/sextrans-2012-050856","article-title":"Condoms for prisoners: no evidence that they increase sex in prison, but they increase safe sex","volume":"89","author":"T Butler","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"3","key":"pone.0321464.ref037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/sti.2006.022996","article-title":"Do condoms cause rape and mayhem? The long-term effects of condoms in New South Wales\u2019 prisons","volume":"83","author":"L Yap","year":"2007","journal-title":"Sex Transm Infect"},{"issue":"9769","key":"pone.0321464.ref038","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","article-title":"The health of prisoners","volume":"377","author":"S Fazel","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"pone.0321464.ref039","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1353\/hpu.2011.0084","article-title":"Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use","volume":"22","author":"M Pe\u00f1a-Orellana","year":"2011","journal-title":"J Health Care Poor Underserved"},{"key":"pone.0321464.ref040","article-title":"Global State of Harm Reduction survey response","author":"A Ogunrombi","year":"2018","journal-title":"London: Harm ReductionInternational"},{"issue":"4","key":"pone.0321464.ref041","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2105\/AJPH.2017.304248","article-title":"Prison Health Care Governance: Guaranteeing Clinical Independence","volume":"108","author":"J Pont","year":"2018","journal-title":"Am J Public Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:24:22Z","timestamp":1744392262000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321464"}},"subtitle":[],"editor":[{"given":"Yury E","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321464","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}